Original news and analysis on international IP policy
By Nick Wadhams for Intellectual Property Watch NAIROBI, KENYA – Amid fears that huge quantities of counterfeit medicines and pesticides are pouring into Africa, the international law enforcement agency INTERPOL is leading the way to invest more effort and money…
By Kaitlin Mara An avian influenza outbreak would be a public health disaster, but for the World Health Organization to adequately prepare for that risk, member states must come to a resolution on intellectual property issues related to virus and…
Por Catherine Saez Según los oradores de un reciente taller llevado a cabo en Ginebra, debido a la expansión del alcance de las patentes de organismos modificados genéticamente (OMG) y la aplicación de dichos cultivos en la mayoría de los…
By David Cronin for Intellectual Property Watch BRUSSELS – Leading pharmaceutical companies are using the patent system to delay the entry of generic medicines onto the market, the European Commission has alleged, sparking a debate at a conference held here…
[Update from the author: Brazil announced on 19 December adoption of the resolution against the extension of patent rights to second-use drugs and polymorphs. Such patents were seen as subterfuges from the pharmaceutical companies to expand their patent rights. The…
By Catherine Saez With the expanding scope of patents on genetically modified organisms (GMOs) and the implementation of such crops in most countries, farmers’ rights and biodiversity are at risk, and food security has become dependent on a few transnational…
Por Catherine Saez PARÍS – Los participantes de un reciente seminario que tuvo lugar en esta ciudad opinan que la biotecnología necesita considerablemente cambiar su modelo de negocios, restaurar la confianza entre los diferentes actores y establecer cooperaciones. Éstos agregaron…
Par Catherine Saez PARIS – Selon certains participants à un séminaire qui s’est récemment tenu à Paris, le secteur des biotechnologies a sérieusement besoin de modifier son mode de fonctionnement, de restaurer la confiance entre les différents acteurs et d’établir…
By William New CHISINAU, MOLDOVA – Creativity may not be the first thing that comes to mind when travelling through the kilometres of mostly grey, Soviet-era cement-block buildings outlying the capital of Moldova, often referred to as Europe’s poorest state.…
By Catherine Saez
PARIS - Biotechnology is in dire need of a change to its business model, restoring trust among all actors and building partnerships, according to participants in a recent seminar here. After nearly thirty years, the industry still is not making profits, the field seems to be running out of steam, and controversies over patents in the health and agriculture areas have influenced public opinion, they said.